Back to Results
First PageMeta Content
Treatment of bipolar disorder / Mood disorders / Electroconvulsive therapy / Neurotechnology / Major depressive disorder / Psychosis / Antidepressant / Serotonin–norepinephrine–dopamine reuptake inhibitor / Mental disorder / Psychiatry / Medicine / Abnormal psychology


WORLD PSYCHIATRIC ASSOCIATION Position Statement on the Use and Safety of Electroconvulsive Therapy
Add to Reading List

Document Date: 2014-03-13 03:45:31

Open Document

File Size: 79,00 KB

Share Result on Facebook

City

Chichester / /

Company

Lucius SA. / Klimstra SA / John Wiley & Sons Ltd. / Bernstein / New Zealand Journal / McCall / Suzuki / UK Review Group / UK ECT Review Group / /

Continent

Europe / /

Country

New Zealand / United States / Canada / Australia / United Kingdom / /

/

Event

Product Issues / Product Recall / /

Facility

UK National Institute of Clinical Excellence / International College of Psychosomatic Medicine Papadiamantopoulou / National Institute / Cochrane Library / Hospital Medical School Cranmer Terrace London SW17 ORE / Royal College of Psychiatrists / /

/

IndustryTerm

treatment for severe depressive illness / treatment of narcoleptic malignant syndrome / treatment for severe depressive disorder / treatment for certain cases of neuroleptic malignant syndrome / treatment of depressive and other psychiatric disorders / treatment of severe depressive illness / brain imaging studies / /

MedicalCondition

J Affective Disorders / total paralysis / depressive disorders / major depressive disorder / treatment-resistant bipolar disorder / TB / dementia / catatonia / vagotonic bradycardia / neurological disorders / non-delusional depression / retinal detachment / convulsion / catatonic mutism / severe depressive disorder / delusional depression / long term cognitive impairment / non bipolar depression / depressive and other psychiatric disorders / depressive illness / severe depressive illness / disorder / mood disorders / neuroleptic malignant syndrome / particularly depressive disorder / pulmonary diseases / intractable catatonic schizophrenia / illness / Brain tumour / alcoholism / severe mental disorder / increased cognitive impairment / particularly cognitive impairment / treatment-resistant schizophrenia / schizophrenia / personality disorders / cerebral infarction / manic states / depressive disorder / unipolar depression / cerebral seizure / bipolar depression / cardiac arrhythmias / severe and prolonged mania / cognitive impairment / antidepressant-resistant depression / mania / aneurysms / seizure / cognitive dysfunction / several non-mood disorder / psychoses / ruptured aneurysms / myocardial infarction / severe manic disorder / pheochromocytoma / Parkinson’s disease / cardiac disease / anorexia nervosa / melancholia / ventricular fibrillation / delirium / withdrawal symptoms / anterograde amnesia / depression / several disorders / significant memory loss / narcoleptic malignant syndrome / /

MedicalTreatment

premedication / Electroconvulsive Therapy / pharmacotherapy / /

NaturalFeature

Abou-Saleh MT / /

Organization

World Psychiatric Association / Executive Committee / Task Force on Treatment Guidelines / Royal College of Psychiatrists / American Psychiatric Association / UK National Institute of Clinical Excellence / ECT administration / Section / World Federation of Societies of Biological Psychiatry / International College of Psychosomatic Medicine Papadiamantopoulou / National Institute for Clinical Excellence / /

Person

Mohammed T Abou-Saleh / Van Vreeswijk / /

/

Position

President / Yiannis Papakostas _yiargeke@hol.gr_ Ioannis Zervas _Zervas@compulink.gr_ George Christodoulou _gnchrist@compulink.gr_ Secretary for Sections / Chair / Fisher / /

Product

pentothal / symptoms / dantrolene sodium / clozapine / ECT / atropine / pindolol / /

PublishedMedium

Neuropsychopharmacology / The NICE Review / /

SocialTag